Showing results (1-10 of 2,200) with videos related to
Sort By:
Pageof 220
Biomarker Research|June 10, 2014
Micro-RNAs, New performers in multiple myeloma bone marrow microenvironmentJahangir Abdi, Lugui Qiu, Hong ChangClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2015
miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple MyelomaYijun Yang, Fei Li, Manujendra N Saha, et al.Oncotarget|August 6, 2016
Role of micro-RNAs in drug resistance of multiple myelomaJahangir Abdi, Hou Jian, Hong ChangOncotarget|December 12, 2013
Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanismsJahangir Abdi, Guoan Chen, Hong ChangJournal of Hematology & Oncology|March 28, 2013
Targeting p53 by small molecules in hematological malignanciesManujendra N Saha, Lugui Qiu, Hong ChangJournal of Hematology & Oncology|June 19, 2017
Role of epigenetics-microRNA axis in drug resistance of multiple myelomaNasrin Rastgoo, Jahangir Abdi, Jian Hou, et al.Oncotarget|January 16, 2016
MiRNA-29a as a tumor suppressor mediates PRIMA-1Met-induced anti-myeloma activity by targeting c-MycManujendra N Saha, Jahangir Abdi, Yijun Yang, et al.Journal of Clinical Pathology|December 4, 2009
Pharmacological activation of the p53 pathway in haematological malignanciesManujendra N Saha, Johann Micallef, Lugui Qiu, et al.Leukemia|May 11, 2018
Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMSNasrin Rastgoo, Maryam Pourabdollah, Jahangir Abdi, et al.Journal of Hematology & Oncology|October 28, 2017
Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesisJahangir Abdi, Nasrin Rastgoo, Lihong Li, et al.Pageof 220